The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin-Ineligible Patients with Muscle-Invasive Localized Urothelial Carcinoma.
Journal
The oncologist
ISSN: 1549-490X
Titre abrégé: Oncologist
Pays: England
ID NLM: 9607837
Informations de publication
Date de publication:
05 2019
05 2019
Historique:
received:
24
02
2019
accepted:
28
02
2019
pubmed:
31
3
2019
medline:
7
2
2020
entrez:
31
3
2019
Statut:
ppublish
Résumé
This commentary reviews current progress in neoadjuvant immunotherapy for muscle‐invasive localized urothelial carcinoma, highlighting opportunities and challenges with recent neoadjuvant immunotherapy trials.
Identifiants
pubmed: 30926675
pii: theoncologist.2019-0161
doi: 10.1634/theoncologist.2019-0161
pmc: PMC6516125
doi:
Substances chimiques
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Comment
Langues
eng
Sous-ensembles de citation
IM
Pagination
580-583Commentaires et corrections
Type : CommentOn
Déclaration de conflit d'intérêts
Disclosures of potential conflicts of interest may be found at the end of this article.
Références
Oncol Lett. 2012 Apr 1;3(4):855-859
pubmed: 22741006
J Clin Oncol. 2018 Oct 20;:JCO1801148
pubmed: 30343614
Oncologist. 2019 May;24(5):688-690
pubmed: 30728277
Cancer. 2008 Nov 1;113(9):2471-7
pubmed: 18823036
Nature. 2014 Mar 20;507(7492):315-22
pubmed: 24476821
Cancer. 2006 Aug 1;107(3):506-13
pubmed: 16773629
Ann Transl Med. 2018 Jun;6(12):250
pubmed: 30069452
J Clin Oncol. 2011 Jun 10;29(17):2432-8
pubmed: 21555688
Eur Urol. 2015 Jan;67(1):165-170
pubmed: 24472710
J Clin Oncol. 2011 Jun 1;29(16):2171-7
pubmed: 21502557
Clin Genitourin Cancer. 2018 Aug;16(4):e879-e892
pubmed: 29576445
N Engl J Med. 2003 Aug 28;349(9):859-66
pubmed: 12944571
Eur Urol. 2005 Aug;48(2):202-5; discussion 205-6
pubmed: 15939524